ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 9 filers reported holding ACASTI PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,000 | 0.0% | 2,213 | +5.4% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 2,100 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 2,100 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 2,100 | -67.5% | 0.00% | – |
Q2 2020 | $3,000 | +200.0% | 6,461 | +77.8% | 0.00% | – |
Q1 2020 | $1,000 | -85.7% | 3,633 | +26.1% | 0.00% | – |
Q4 2019 | $7,000 | +75.0% | 2,880 | +38.8% | 0.00% | – |
Q3 2019 | $4,000 | -20.0% | 2,075 | -49.5% | 0.00% | – |
Q2 2019 | $5,000 | -44.4% | 4,109 | -51.7% | 0.00% | – |
Q1 2019 | $9,000 | +200.0% | 8,502 | +108.6% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 4,075 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | +66.7% | 4,075 | -25.8% | 0.00% | – |
Q2 2018 | $3,000 | -25.0% | 5,493 | +34.8% | 0.00% | – |
Q1 2018 | $4,000 | – | 4,075 | +5333.3% | 0.00% | – |
Q4 2017 | $0 | – | 75 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 75 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 75 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 75 | -6.2% | 0.00% | – |
Q4 2016 | $0 | – | 80 | +6.7% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 75 | -87.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 575 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 575 | -2.2% | 0.00% | – |
Q4 2015 | $1,000 | – | 588 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 236,559 | $414,000 | 0.03% |
INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $206,000 | 0.01% |
Virtu KCG Holdings LLC | 29,187 | $52,000 | 0.00% |
TORONTO DOMINION BANK | 25 | $0 | 0.00% |
BANK OF MONTREAL /CAN/ | 177,389 | $317,000 | 0.00% |
Tower Research Capital LLC (TRC) | 600 | $1,000 | 0.00% |
Renaissance Technologies | 35,400 | $63,000 | 0.00% |
ROYAL BANK OF CANADA | 75 | $0 | 0.00% |
UBS Group AG | 1,061 | $2,000 | 0.00% |